StockData

HCW Biologics vs Marker Therapeutics

HCWB and MRKR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HCWB and MRKR compare

Marker Therapeutics is the larger company, worth 10 times as much as HCW Biologics ($14.5M against $1.4M).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHCWBMRKR
Size and price
Market cap$1.4M$14.5M
Share price$0.773$0.870
Change, 1 year−95.0%−7.8%
Change, 5 years−99.9%−93.3%
Beta (5Y)0.741.27
Employees–5
StockData Score
Total score66
Valuation score3 (better)1
Growth score2 (better)0
Performance score1 (better)0
Health score05 (better)
Dividend score00
Valuation
P/S0.2×–
P/B0.2× (better)1.2×
Fair value$14.72–
Margin of safety94.7%–
Growth
Revenue growth (TTM)700%–
Revenue growth, 5Y average−57.9%48.0% (better)
Profitability
Gross margin96.7%–
Operating margin−115%–
Net margin−83.8%–
Return on equity−151%−76.9% (better)
Return on invested capital−70.7%–
Financial health
Debt / equity0.88 (better)0.00
Interest coverage−14.0×–
Current ratio0.066.03 (better)
Altman Z-score−7.21 (better)−42.38
Piotroski F-score22
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions5.6%23.8%
Held by insiders34.9%31.9%
Insider net buying, 12 months$532K–
Short interest, % of float4.1%1.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.